Researchers recently reported a preliminary signal of possible structural damage in the kidneys of six patients after long-term treatment with a renin-angiotensin system (RAS) inhibitor, a superclass ...

Medically reviewed by Jamin Brahmbhatt, MD IgA nephropathy (IgAN) is a kidney condition where antibodies (immune system ...

Since the introduction of ARBs, the question that has pervaded each clinician’s mind is whether or not these drugs serve an advantage in conditions long addressed by ACE inhibitors. Matchar et al ...

Medically reviewed by Matthew Wosnitzer, MD Complement 3 glomerulopathy (C3G) is a rare kidney disease that is also ...

It's long been known that use of a renin-angiotensin-aldosterone system (RAAS) antagonist slows the progression of kidney disease and specifically slows progression of advanced kidney disease, ...

Close-up of senior black woman sorting weekly medication. Member of a black middle class America family. Currently, ACE inhibitors and ARBs are both recommended as first-line therapies for the ...

Please provide your email address to receive an email when new articles are posted on . Patients should be counseled about ARBs, ACE inhibitors, NSAIDs and proton pump inhibitors. Optometrists need to ...

Please provide your email address to receive an email when new articles are posted on . Patients with albuminuric chronic kidney disease without diabetes can experience a significantly increased ...